The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Open accessAbstract
The mammalian body has a highly developed immune system which guards against continuous invading protein attacks and aims at preventing, attenuating or repairing the inflicted damage. It is conceivable that through evolution analogous biological protective systems have been evolved against non-protein attacks. There is emerging evidence that lipid endocannabinoid signaling through cannabinoid 2 (CB2) receptors may represent an example/part of such a protective system/armamentarium. Inflammation/tissue injury triggers rapid elevations in local endocannabinoid levels, which in turn regulate signaling responses in immune and other cells modulating their critical functions. Changes in endocannabinoid levels and/or CB2 receptor expressions have been reported in almost all diseases affecting humans, ranging from cardiovascular, gastrointestinal, liver, kidney, neurodegenerative, psychiatric, bone, skin, auto-immune, lung disorders to pain and cancer, and modulating CB2 receptor activity holds tremendous therapeutic potential in these pathologies. While CB2 receptor activation in general mediates immunosuppressive effects, which limit inflammation and associated tissue injury in large number of pathological conditions, in some disease states activation of the CB2 receptor may enhance or even trigger tissue damage, which will also be discussed alongside the protective actions of the CB2 receptor stimulation with endocannabinoids or synthetic agonists, and the possible biological mechanisms involved in these effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–271 of 271
Latest advances in cannabinoid receptor agonists
Thakur, G. A., Tichkule, R. B., Bajaj, S., & Makriyannis, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903436505 · Cited by 103
Zheng, D., Bode, A. M., Zhao, Q. J., Cho, Y., Zhu, F., Ma, W.-Y., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6594 · Cited by 102
Borrelli, F., & Izzo, A. A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.003 · Cited by 100
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99 · cited 1×
“Some of these enzymes exist in several forms and their levels of activity vary in different tissues [59–63].”
BackgroundNúñez, E., Benito, C., Tolón, R. M., Hillard, C. J., Griffin, W. S. T., & Romero, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.029 · Cited by 99
Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?
Fowler, C. J., Rojo, M. L., & Rodríguez‐Gaztelumendi, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.021 · Cited by 97
Sewell, R. A., Ranganathan, M., & D’Souza, D. C. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782802 · Cited by 97
Bouchard, J., Lépicier, P., & Lamontagne, D. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02474-8 · Cited by 93
Zhao, Y., Yuan, Z., Liu, Y., Xue, J., Tian, Y., Liu, W., Zhang, W., Shen, Y., Xu, W., Liang, X., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d2644d · Cited by 92
Cannabinoid CB2 Receptors in Health and Disease
Patel, K. D., Davison, J. S., Pittman, Q. J., et al. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980041 · Cited by 92
Oleoyl serine, an endogenous N -acyl amide, modulates bone remodeling and mass
Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., Ofek, O., Stuart, J. M., Bajayo, A., Tam, J., Kram, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912479107 · Cited by 91
Self-citationEndocannabinoids and the Heart
Hiley, C. R. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318192671d · Cited by 90
Yamada, Y., Ando, F., & Shimokata, H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.791 · Cited by 89
Weis, F. C., Beiras-Fernández, A., Sodian, R., Kaczmarek, I., Reichart, B., Beiras, A., Schelling, G., & Kreth, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.025 · Cited by 89
Murineddu, G., Lazzari, P., Ruiu, S., Sanna, A., Loriga, G., Manca, I., Falzoi, M., Dessì, C., Curzu, M. M., Chelucci, G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060920d · Cited by 86
Cannabinoid receptors in acute and chronic complications of atherosclerosis
Mach, F., Montecucco, F., & Steffens, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707517 · Cited by 85
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 83
Self-citationEsposito, G., Iuvone, T., Savani, C., Scuderi, C., Filippis, D. D., Papa, M., Marzo, V. D., & Steardo, L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121566 · Cited by 83
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Zamora‐Valdés, D., Pichardo-Bahena, R., Barredo-Prieto, B. A., Ponciano‐Rodríguez, G., Bermejo-Martínez, L., Chávez-Tapia, N. C., González, H. A. B., & Uribe, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01401.x · Cited by 83
Siegmund, S., & Schwabe, R. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2007 · Cited by 80
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 79
Montecucco, F., Matias, I., Lenglet, S., Petrosino, S., Burger, F., Pelli, G., Braunersreuther, V., Mach, F., Steffens, S., & Marzo, V. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.040 · Cited by 77
Brown, A. J., Daniels, D. A., Kassim, M., Brown, S. A., Haslam, C. P., Terrell, V. R., Brown, J. D., Nichols, P. L., Staton, P. C., Wise, A., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.172650 · Cited by 75
Ueda, Y., Miyagawa, N., Matsui, T., Kaya, T., & IWAMURA, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.013 · Cited by 73
Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice ☆
Jan, T., Farraj, A. K., Harkema, J. R., & Kaminski, N. E. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00010-3 · Cited by 72
The Role of the Endocannabinoid System in Atherosclerosis
Mach, F., & Steffens, S. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01685.x · Cited by 72
CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
Csóka, B., Németh, Z. H., Mukhopadhyay, P., Spolarics, Z., Rajesh, M., Federici, S., Deitch, E. A., Bátkai, S., Pacher, P., & Haskó, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006409 · Cited by 72
Self-citationExpression and function of cannabinoid receptors in mouse islets
Li, C., Bowe, J. E., & Jones, P. M. (2010) · Islets · doi:10.4161/isl.2.5.12729 · Cited by 68
Hall, D., Poussin, C., Velagapudi, V., Empsen, C., Joffraud, M., Beckmann, J. S., Geerts, A. E., Ravussin, Y., Ibberson, M. R., Orešič, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127159 · Cited by 67
Endocannabinoid system modulation in cancer biology and therapy
Pisanti, S., & Bifulco, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.011 · Cited by 67
Avraham, Y., Israeli, E., Gabbay, E., Okun, A., Zolotarev, O., Silberman, I., Ganzburg, V., Dagon, Y., Magen, I., Vorobia, L., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.008 · Cited by 66
Self-citationThe endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
Rossi, F., Bellini, G., Luongo, L., Torella, M., Mancusi, S., PETROCELLIS, L. D., Petrosino, S., Siniscalco, D., Orlando, P., Scafuro, M., et al. (2011) · Bone · doi:10.1016/j.bone.2011.01.001 · Cited by 66
Maccarrone, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707444 · Cited by 65
Cannabinoid Type 2 Receptor as a Target for Chronic - Pain
Beltramo, M. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001785 · Cited by 62
The Endocannabinoid System and Alzheimer’s Disease
Benito, C., Núñez, E., Pazos, M. R., Tolón, R. M., & Romero, J. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8006-8 · Cited by 62
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells
Li, C., Jones, P. M., & Persaud, S. J. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320527 · Cited by 61
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
Filippis, D. D., D’Amico, A., & Iuvone, T. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01674.x · Cited by 60
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 60
Self-citationCannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
Michalski, C. W., Maier, M., Erkan, M., Sauliunaite, D., Bergmann, F., Pacher, P., Bátkai, S., Giese, N. A., Giese, T., Frieß, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001701 · Cited by 56
Self-citationNovel Natural and Synthetic Ligands of the Endocannabinoid System
Hanus, L. O., & Mechoulam, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980096 · Cited by 56
Self-citationImmunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS
Gorantla, S., Makarov, E., Roy, D., Finke-Dwyer, J., Murrin, L. C., Gendelman, H. E., & Poluektova, L. Y. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9225-8 · Cited by 55
Wiley, J. L., Beletskaya, I. D., Ng, E. W., Dai, Z., Crocker, P. J., Mahadevan, A., Razdan, R. K., & Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.679 · Cited by 54
Marihuana as medicine. A plea for reconsideration.
Grinspoon, L., & Bakalar, J. B. (1995) · PubMed · Cited by 53
Pacher, P., & Gao, B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00523.2007 · Cited by 52
Self-citationCannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis
Domenicali, M., Caraceni, P., Giannone, F. A., Pertosa, A. M., Principe, A., Zambruni, A., Trevisani, F., Croci, T., & Bernardi, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.004 · Cited by 50
Possible Anandamide and Palmitoylethanolamide involvement in human stroke
Naccarato, M., Pizzuti, D., Petrosino, S., Simonetto, M., Ferigo, L., Grandi, F., Pizzolato, G., & Marzo, V. D. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-47 · Cited by 49
Dagon, Y., Avraham, Y., Ilan, Y., Mechoulam, R., & Berry, E. M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7705com · Cited by 48
Self-citationEndocannabinoid signaling in neurotoxicity and neuroprotection
Pope, C., Mechoulam, R., & Parsons, L. H. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.002 · Cited by 47
Self-citationSelective CB2 up‐regulation in women affected by endometrial inflammation
Iuvone, T., Filippis, D. D., Sardo, A. D. S., D’Amico, A., Simonetti, S., Sparice, S., Esposito, G., Bifulco, G., Insabato, L., Nappi, C., et al. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00085.x · Cited by 42
Anandamide serves two masters in the brain
Marzo, V. D. (2010) · Nature Neuroscience · doi:10.1038/nn1210-1446 · Cited by 38
Targeting the Endocannabinoid System for the Treatment of Cancer – A Practical View
Fowler, C. J., Gustafsson, S. B., Chung, S. C., Persson, E., Jacobsson, S. O. P., & Bergh, A. R. J. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791164201 · Cited by 37
The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
Lamontagne, D., Lépicier, P., Lagneux, C., & Bouchard, J. (2006) · PubMed · Cited by 35
March, Z. D., Zuccato, C., Giampà, C., Patassini, S., Bari, M., Gasperi, V., CEBALLOS, M. L. D., Bernardi, G., Maccarrone, M., Cattaneo, E. F., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.044 · Cited by 34
Cannabinoid CB 1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders
Pacher, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178129 · Cited by 34
Self-citationSignaling Pathways Involved in the Cardioprotective Effects of Cannabinoids
Lépicier, P., Bibeau-Poirier, A., Lagneux, C., Servant, M. J., & Lamontagne, D. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06011x · Cited by 33
Brogi, S., Corelli, F., Marzo, V. D., Ligresti, A., Mugnaini, C., Pasquini, S., & Tafi, A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.034 · Cited by 33
2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver
Kurabayashi, M., Takeyoshi, I., Yoshinari, D., Matsumoto, K., Maruyama, I., & Morishita, Y. (2005) · Journal of Investigative Surgery · doi:10.1080/08941930590905189 · Cited by 32
Srivastava, B. K., Soni, R., Patel, J. Z., Joharapurkar, A. A., Sadhwani, N., Kshirsagar, S. G., Mishra, B. A., Takale, V., Gupta, S. V., Pandya, P., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.046 · Cited by 27
Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice
Ueda, Y., Miyagawa, N., & Wakitani, K. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.026 · Cited by 24
Petrella, C., Agostini, S., Alemà, G., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., & Broccardo, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01569.x · Cited by 23
Hengstenberg, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000004 · Cited by 21
Fukuda, H., Abe, T., & Yoshihara, S. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000283042 · Cited by 19
Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands
Tong, L., SHANKAR, B. B., Chen, L., Rizvi, R. K., Kelly, J. M., Gilbert, E. J., Huang, C., Yang, D., Kozlowski, J. A., Shih, N., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.126 · Cited by 19
Lange, J. H. M., van der Neut, M. A. W., Borst, A. J. M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.068 · Cited by 18
The Cannabinoid Receptor Agonist WIN 55212-2 Inhibits Neurogenic Inflammations in Airway Tissues
Yoshihara, S., Morimoto, H., Ohori, M., Yamada, Y., Abe, T., & Arisaka, O. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050171 · Cited by 17
Patel, M. B., Gomes, B. A., Patel, C. N., & Yoburn, B. C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01823-x · Cited by 17
Pacher, P., & Ungvari, Z. I. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00020.2008 · Cited by 17
Self-citationCannabinoids hurt, heal in cirrhosis
Kunos, G., Osei‐Hyiaman, D., Bátkai, S., & Gao, B. (2006) · Nature Medicine · doi:10.1038/nm0606-608 · Cited by 16
Ishii, Y., Sakamoto, T., Ito, R., & Yanaga, K. K. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.01.026 · Cited by 16
Sanchez, N. M., Valdés, D., Bahena, R. P., et al. (2007) · Cited by 10
Endocannabinoids, CB1 Receptors, and Liver Disease: Hitting More Than One Bird With the Same Stone
Kunos, G., & Gao, B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.017 · Cited by 8
Cited by
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
“F or p er so na l u se o nl y.”
BackgroundInfluentialSelf-citationGeneral Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation
Yam, M. F., Loh, Y. C., Tan, C. S., Khadijah Adam, S., Abdul Manan, N., & Basir, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082164 · Cited by 652
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Self-citationThe Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Silvestri, C., & Di Marzo, V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 543
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Metadata
- Authors
- Pacher, P., & Mechoulam, R.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 50
- Issue
- 2
- Pages
- 193-211
- ISSN
- 0163-7827 (ISSN-L)
- OpenAlex
- W2144797452
- Cited by
- 414
- References
- 271
- FWCI
- 25.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.